IN192057B - - Google Patents

Info

Publication number
IN192057B
IN192057B IN779DE2001A IN192057B IN 192057 B IN192057 B IN 192057B IN 779DE2001 A IN779DE2001 A IN 779DE2001A IN 192057 B IN192057 B IN 192057B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Swargam Sathyanarayana
Yatendra Kumar
Tarun Kant Sharma
Sujay Biswas
B Vijayaraghavan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN779DE2001 priority Critical patent/IN192057B/en
Priority to EP02745709A priority patent/EP1412340A4/en
Priority to AU2002317420A priority patent/AU2002317420A1/en
Priority to PCT/IB2002/002728 priority patent/WO2003007872A2/en
Priority to CA002454335A priority patent/CA2454335A1/en
Priority to ARP020102723A priority patent/AR037493A1/es
Publication of IN192057B publication Critical patent/IN192057B/en
Priority to US10/484,296 priority patent/US20040254385A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
IN779DE2001 2001-07-19 2001-07-19 IN192057B (es)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN779DE2001 IN192057B (es) 2001-07-19 2001-07-19
EP02745709A EP1412340A4 (en) 2001-07-19 2002-07-11 METHOD FOR PRODUCING CITALOPRAMHYDROBROMID
AU2002317420A AU2002317420A1 (en) 2001-07-19 2002-07-11 Process for the preparation of citalopram hydrobromide
PCT/IB2002/002728 WO2003007872A2 (en) 2001-07-19 2002-07-11 Process for the preparation of citalopram hydrobromide
CA002454335A CA2454335A1 (en) 2001-07-19 2002-07-11 Process for the preparation of citalopram hydrobromide
ARP020102723A AR037493A1 (es) 2001-07-19 2002-07-19 Proceso para la preparacion de hidrobromuro de citalopram
US10/484,296 US20040254385A1 (en) 2001-07-19 2004-05-18 Process for the preparation of citalopram hydrobromide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN779DE2001 IN192057B (es) 2001-07-19 2001-07-19

Publications (1)

Publication Number Publication Date
IN192057B true IN192057B (es) 2004-02-14

Family

ID=11097086

Family Applications (1)

Application Number Title Priority Date Filing Date
IN779DE2001 IN192057B (es) 2001-07-19 2001-07-19

Country Status (7)

Country Link
US (1) US20040254385A1 (es)
EP (1) EP1412340A4 (es)
AR (1) AR037493A1 (es)
AU (1) AU2002317420A1 (es)
CA (1) CA2454335A1 (es)
IN (1) IN192057B (es)
WO (1) WO2003007872A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002597A2 (en) 2005-06-27 2007-01-04 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
WO2009007658A2 (fr) * 2007-07-10 2009-01-15 Thomson Licensing Procede de determination d ' un group de pairs situes dans le voisinage d ' un autre pair, et serveur, dispositifs d ' analyse associes
PE20091156A1 (es) * 2007-12-17 2009-09-03 Astrazeneca Ab Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
DK2595979T3 (en) 2010-07-23 2016-05-17 Lundbeck & Co As H A process for the purification of pharmaceutically acceptable salts of escitalopram
CN103936702A (zh) * 2014-05-07 2014-07-23 成都诺维尔生物医药有限公司 艾司西酞普兰杂质j的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
DK1015416T3 (da) * 1997-07-08 2001-11-05 Lundbeck & Co As H Fremgangsmåde til fremstilling af citalopram
AR032455A1 (es) * 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva

Also Published As

Publication number Publication date
US20040254385A1 (en) 2004-12-16
WO2003007872A3 (en) 2003-10-23
EP1412340A4 (en) 2004-12-01
EP1412340A2 (en) 2004-04-28
AU2002317420A1 (en) 2003-03-03
WO2003007872A2 (en) 2003-01-30
CA2454335A1 (en) 2003-01-30
AR037493A1 (es) 2004-11-17

Similar Documents

Publication Publication Date Title
BE2022C531I2 (es)
BE2022C547I2 (es)
BE2017C057I2 (es)
BE2017C051I2 (es)
BE2017C032I2 (es)
BE2016C051I2 (es)
BE2015C077I2 (es)
BE2015C046I2 (es)
BE2014C052I2 (es)
BE2014C036I2 (es)
BE2014C026I2 (es)
BE2014C004I2 (es)
BE2014C006I2 (es)
BE2017C050I2 (es)
BE2011C034I2 (es)
BE2007C047I2 (es)
AU2002307149A8 (es)
JP2002043441A5 (es)
HU0201385D0 (es)
BE2014C008I2 (es)
BRPI0204884A2 (es)
CH1379220H1 (es)
BE2016C021I2 (es)
JP2002026944A5 (es)
JP2002183345A5 (es)